cas 1415226-40-2|| where to buy 5-(3-Chlorophenyl)-3-hydroxypicolinic acid

Nombre del producto:5-(3-Chlorophenyl)-3-hydroxypicolinic acid

IUPAC Name:5-(3-chlorophenyl)-3-hydroxypyridine-2-carboxylic acid

Unidad de embalaje	Stock disponible	Precio($)
CM249306-100mg	in stock	ȤȤ
CM249306-250mg	in stock	ƅǺƩ
CM249306-1g	in stock	ǺƩǆ
CM249306-5g	1-2 Weeks	ǆȤœ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1415226-40-2 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :1415226-40-2; Fórmula molecular:C12H8ClNO3; Punto de fusión:-; Código de sonrisas:O=C(C1=NC=C(C2=CC=CC(Cl)=C2)C=C1O)O; Densidad:

: Número de catálogo:CM249306; Peso molecular:249.65; Punto de ebullición:; Nº Mdl:MFCD30802547; Almacenamiento:

: Pyridines; Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.; Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu; Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer; Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

: Vadadustat; March 27, 2024, Akebia received FDA approval of Vafseo(vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis.
Vafseo(vadadustat) tablets is a once-daily oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor that activates the physiologic response to hypoxia to stimulate endogenous production of erythropoietin, increasing hemoglobin and red blood cell production to manage anemia.